MedTrace Logo

Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event

NCT00241748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2012-01-05

No results posted yet for this study

Summary

To conduct a case-control study of factors that increased the risk of rhabdomyolysis, an adverse drug reaction in cerivastatin users

Conditions

  • Rhabdomyolysis

Sponsors & Collaborators

Principal Investigators

  • Bruce M Psaty, MD, PhD · University of Washington

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241748 on ClinicalTrials.gov